D. E. Shaw & Co., Inc. Bio Rad Laboratories, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $20.9 Million - $25.2 Million	-50,000 Reduced 83.33%	10,000 $4.79 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $13.7 Million - $17.8 Million	-39,000 Reduced 39.39%	60,000 $25.2 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $3.18 Million - $4.34 Million	7,700 Added 8.43%	99,000 $41.3 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $22.4 Million - $28.9 Million	48,400 Added 112.82%	91,300 $45.2 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $5.88 Million - $8.24 Million	11,200 Added 35.33%	42,900 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $15.4 Million - $17.2 Million	21,700 Added 217.0%	31,700 $24 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $3.55 Million - $4.46 Million	-5,400 Reduced 35.06%	10,000 $7.46 Million
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $2.92 Million - $4.13 Million	-13,000 Reduced 45.77%	15,400 $4.71 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $6.25 Million - $8.78 Million	28,400 New	28,400 $6.6 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.